Cargando...
Guselkumab for the treatment of psoriasis – evidence to date
Psoriasis is a chronic, immune-mediated, inflammatory, and debilitating skin disease with significant impact on patients’ quality of life. Its pathogenesis is complex and not yet fully understood. However, the IL-23/IL-17 axis is currently considered the main pathogenic pathway in psoriasis. Guselku...
Guardado en:
| Publicado en: | Drugs Context |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BioExcel Publishing Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6668503/ https://ncbi.nlm.nih.gov/pubmed/31391856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212594 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|